A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2

N/ATerminatedNCT01197963

The University of Texas Health Science Center, Houston3 enrolled

Overview

The purpose of the study is to determine if by performing surgery we can cure Type II Diabetes. The surgical procedures: 1. a sleeve gastrectomy, cutting out a portion of the stomach, which provides restriction of caloric intake and rapid gastric emptying. 2. ileal transposition which involves repositioning a 150cm segment of the ileum into the jejunum causing improved glucose homeostasis.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Type 2 Diabetes Mellitus

Interventions

Sleeve Gastrectomy and Ileal transpositionPROCEDURE

Laparoscopic sleeve gastrectomy with ileal transposition

dietary and medical managementDIETARY_SUPPLEMENT

dietary and medical routine management patients are currently following with an endocrinologist.

Eligibility

Sex: ALLMin age: 21 YearsMax age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age- 21-55 years. * Body Mass Index between 25-35 kf/m2. * currently being treated for type 2 diabetes mellitus with oral hypoglycemic, insulin or both for the at least 3 years. * Documented HbA1c\>7.5% for at least 3 months. * Stable weight for 3 months (+/-) * Evidence of stable medical treatment for diabetes over the past 12 months. * Able to provide informed consent -Female subject agrees to participate in accepted birth control methods - Exclusion Criteria: * Type I diabetes/juvenile onset * C-Peptid levels below 1.0 ng/ml * Previous major upper abdominal surgery --Pregnant or plans to become pregnant with in the next 12 months * Current Malignancy * Severe pulmonary, cardia, or renal disease * Eating disorders such as bulimia or binge-eating * Severe mental health disorders such as schizophrenia and bipolar disorder * Obesity due to other metabolic disorders * taking appetite suppressants * currently abusing illicit drugs,alcohol or using tobacco products * Unable to provide informed consent * Unwillingness or unable to comply with study procedures * any condition that deems them unsuitable for the study in the opinion of the investigators

Locations (1)

The University of Texas

Bellaire, Texas, United States

Outcomes

Primary Outcomes

Serial Postoperative HgA1c levels

Effectiveness of the transposition to alleviate hyperglycemia will be measured by following serial post operative HbA1c levels. The change from baseline mearusements will be used to determine the outcome. Type 2 diabetes is considered resolved if there is normalization of fasting glucose(\<110 mg/dl) normal HbA1c (\<6%) and no need for diabetic medications.

Time frame: 1 month intervals for 3 months then every 3 months there after

Secondary Outcomes

Serial Postoperative Lipid Profiles levels

Lipid profiles will be examined at follow up witha goal of total cholesterol \<200 mg/dl, low-density lipoprotein (LDL) levels \<100 mg/dl, triglyceride levels \<150 mg/dl, and high-density lipoprotein (HDL) levels \>40 mg/dl. Patients will be fasting for 8 hours and the serum glucose and GLP-1 level will be checked.

Time frame: 1 month for the first 3 months then every 3 months there after

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.